PHASE-II TRIAL OF COMBINATION CHEMOTHERAPY FOR PANCREATIC-CANCER WITH 5-FLUOROURACIL, MITOMYCIN-C, AND HEXAMETHYLMELAMINE

被引:14
作者
BRUCKNER, HW
STORCH, JA
BROWN, JC
GOLDBERG, J
CHAMBERLIN, K
机构
[1] CUNY MT SINAI SCH MED,DEPT NEOPLAST DIS,NEW YORK,NY 10029
[2] CUNY MT SINAI SCH MED,DEPT MED MED ONCOL,NEW YORK,NY 10029
关键词
D O I
10.1159/000225717
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:165 / 169
页数:5
相关论文
共 11 条
[1]  
[Anonymous], 1979, Ann Surg, V189, P205
[2]  
BRUCKNER HW, 1982, ONCOLOGY
[3]  
BUROKER T, 1978, P AM ASSOC CANC RES, V19, P310
[4]   EVALUATION OF CYTOTOXIC AGENTS IN HUMAN COLONIC TUMOR XENOGRAFTS AND MOUSE GASTRO-INTESTINAL TISSUES USING A THYMIDINE-H-3 FRACTIONAL INCORPORATION ASSAY [J].
HOUGHTON, JA ;
HOUGHTON, PJ .
EUROPEAN JOURNAL OF CANCER, 1979, 15 (05) :763-769
[5]   COMPARATIVE TOXICITY ON LEUKOCYTES AND PLATELETS OF 2 REGIMENS OF CCNU - RELATIONSHIP BETWEEN MAXIMUM DOSE AND OPTIMUM DOSE [J].
ISRAEL, L ;
CHAHINIAN, P .
EUROPEAN JOURNAL OF CANCER, 1973, 9 (11-1) :799-802
[6]  
SCHEIN PS, 1978, CANCER, V42, P19, DOI 10.1002/1097-0142(197807)42:1<19::AID-CNCR2820420103>3.0.CO
[7]  
2-4
[8]  
SMITH FP, 1979, SEMIN ONCOL, V6, P368
[9]  
STOLINSK.DC, 1972, CANCER, V30, P61, DOI 10.1002/1097-0142(197207)30:1<61::AID-CNCR2820300110>3.0.CO
[10]  
2-O